{"id": "236948", "url": "https://fevir.net/resources/Group/236948", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/comparator-group"], "versionId": "74", "lastUpdated": "2026-01-29T20:46:07.401Z"}, "type": "person", "title": "GLP-1 RA Group in Adults with type 2 diabetes", "status": "active", "contact": [{"telecom": [{"value": "support@computablepublishing.com", "system": "email"}]}], "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "extension": [{"url": "http://hl7.org/fhir/StructureDefinition/artifact-author", "valueContactDetail": {"name": "Computable Publishing\u00ae: MAGIC-to-FEvIR Converter"}}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact", "valueRelatedArtifact": {"type": "part-of", "resourceReference": {"type": "Composition", "display": "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-conversion-report", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}}}, {"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as", "valueMarkdown": "GLP-1 RA Group in Adults with type 2 diabetes [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing\u00ae: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236948. Revised 2026-01-29. Available at: https://fevir.net/resources/Group/236948. Computable resource at: https://fevir.net/resources/Group/236948#json."}], "publisher": "Computable Publishing LLC", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"code": "ACSN", "system": "http://terminology.hl7.org/CodeSystem/v2-0203", "display": "Accession ID"}]}, "value": "236948", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}, {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-comparator-group-MAGIC-5288-j1Wqrn-comparator-85394-C-85798", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}], "membership": "enumerated", "useContext": [{"code": {"code": "evidence-communication", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Evidence Communication"}, "valueCodeableConcept": {"coding": [{"code": "ComparatorGroup", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "ComparatorGroup"}]}}], "description": "Glucagon-Like Peptide-1 (GLP-1) receptor agonists", "resourceType": "Group", "characteristic": [{"code": {"text": "Member of"}, "exclude": false, "description": "inclusion in Adults with type 2 diabetes", "valueReference": {"type": "Group", "display": "Adults with type 2 diabetes and CVD and CKD", "reference": "Group/236947", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-population-group-85394-85798", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}}, {"code": {"text": "Exposed to"}, "exclude": false, "description": "received GLP-1 RA", "valueReference": {"type": "Group", "display": "Glucagon-Like Peptide-1 (GLP-1) receptor agonists", "reference": "Group/236776", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-comparator-85394-C-85798", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}}], "combinationMethod": "all-of"}